Recent breakthroughs in therapies and diagnostics are creating real hope in Alzheimer's disease care — especially for treating early symptomatic stages of the disease. But despite this progress, major healthcare system and awareness gaps still risk leaving too many people behind.
We sat down with Laura Steele, Senior Vice President of U.S. Neuroscience at Lilly, to unpack how scientific progress has produced innovations that can improve detection and diagnosis for people with Alzheimer's disease. She also discussed what health care providers and policymakers must do to unlock the full value of these innovations.
Seven people at Joint Base Andrews fell ill after a "suspicious package" containing "negative sentiments" towards President Trump and his actions was sent to the Maryland military facility, the U.S. military said Friday.
The latest: "There were no specific threats towards the President or other government officials" in the package that was sent Thursday, but the statement from the 316th Wing of the U.S. Air Force at the base said "emergency responders evacuated the building and connecting building and established a cordon around the area" as a precaution.
Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk to cut prices for blockbuster diabetes and anti-obesitydrugs.
Why it matters: About 10% of Medicare enrollees will be newly eligible for coverage of GLP-1 drugs because of the deal, a senior administration official told reporters Thursday.
The Affordable Care Act's subsidy structure, especially with COVID-era enhancements, discriminates against people with employer insurance and creates disincentives to work, an influential conservative think tank argues in a new brief provided first to Axios.
Why it matters: Treat this as a preview of a likely new line of attack on the Hill as Congress continues to brawl over the future of the enhanced subsidies.
Liberal Democrats dug in Wednesday after Tuesday's elections, maintaining their health care push as moderate Democrats were quieter and said talks are continuing.
Why it matters: The aftermath of Democrats' big election night wins highlighted the strains within the Democratic Party over how long to keep battling Republicans for extending enhanced Affordable Care Act tax credits.
